161 related articles for article (PubMed ID: 2354230)
1. Plasmatic vasopressin neurophysin in depression: basic levels and relations with HPA axis.
Laruelle M; Seghers A; Goffinet S; Bouchez S; Legros JJ
Biol Psychiatry; 1990 Jun; 27(11):1249-63. PubMed ID: 2354230
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin-neurophysin and DST in major depression: relationship with suicidal behavior.
Pitchot W; Scantamburlo G; Pinto E; Hansenne M; Reggers J; Ansseau M; Legros JJ
J Psychiatr Res; 2008 Jul; 42(8):684-8. PubMed ID: 17720191
[TBL] [Abstract][Full Text] [Related]
3. Plasma vasopressin and human neurophysins in physiological and pathological states associated with changes in vasopressin secretion.
Pullan PT; Clappison BH; Johnston CI
J Clin Endocrinol Metab; 1979 Oct; 49(4):580-7. PubMed ID: 479348
[TBL] [Abstract][Full Text] [Related]
4. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic function and the cortisol response to dexamethasone in depression.
Rubin AL; Price LH; Charney DS; Heninger GR
Psychiatry Res; 1985 May; 15(1):5-15. PubMed ID: 2989963
[TBL] [Abstract][Full Text] [Related]
6. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
Meador-Woodruff JH; Haskett RF; Grunhaus L; Akil H; Watson SJ; Greden JF
Biol Psychiatry; 1987 Sep; 22(9):1137-50. PubMed ID: 2958096
[TBL] [Abstract][Full Text] [Related]
7. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
[TBL] [Abstract][Full Text] [Related]
8. Plasma endogenous opioids and dexamethasone suppression test in depression.
Kärkkäinen J; Laatikainen T; Naukkarinen H; Salminen K; Spoov J; Stenman UH; Rimon R
Psychiatry Res; 1987 Jun; 21(2):151-9. PubMed ID: 2956623
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls.
Thompson LM; Rubin RT; McCracken JT
Psychoneuroendocrinology; 1992 Oct; 17(5):507-15. PubMed ID: 1484917
[TBL] [Abstract][Full Text] [Related]
10. Abnormal pituitary function during melancholia: reduced alpha-melanocyte-stimulating hormone secretion and increased intact ACTH non-suppression.
Maes M; DeJonckheere C; Vandervorst C; Schotte C; Cosyns P; Raus J; Suy E
J Affect Disord; 1991 Jul; 22(3):149-57. PubMed ID: 1655852
[TBL] [Abstract][Full Text] [Related]
11. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia.
Ryan MC; Sharifi N; Condren R; Thakore JH
Psychoneuroendocrinology; 2004 Sep; 29(8):1065-70. PubMed ID: 15219658
[TBL] [Abstract][Full Text] [Related]
12. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients.
Axelson DA; Doraiswamy PM; Boyko OB; Rodrigo Escalona P; McDonald WM; Ritchie JC; Patterson LJ; Ellinwood EH; Nemeroff CB; Krishnan KR
Psychiatry Res; 1992 Oct; 44(1):63-70. PubMed ID: 1461948
[TBL] [Abstract][Full Text] [Related]
13. Cortisol secretion in endogenous depression. II. Time-related functions.
Halbreich U; Asnis GM; Shindledecker R; Zumoff B; Nathan RS
Arch Gen Psychiatry; 1985 Sep; 42(9):909-14. PubMed ID: 4037991
[TBL] [Abstract][Full Text] [Related]
14. HPA axis abnormalities in depressed patients with normal response to the DST.
Meller W; Kathol RG; Jaeckle RS; Grambsch P; Lopez JF
Am J Psychiatry; 1988 Mar; 145(3):318-24. PubMed ID: 2830798
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients.
Roy M; Collier B; Roy A
Psychiatry Res; 1990 Jan; 31(1):31-7. PubMed ID: 2156275
[TBL] [Abstract][Full Text] [Related]
16. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
[TBL] [Abstract][Full Text] [Related]
17. A multivariate study of simultaneous escape from suppression by dexamethasone of urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and beta-endorphin in melancholic patients.
Maes M; Vandervorst C; Suy E; Minner B; Raus J
Acta Psychiatr Scand; 1991 Jun; 83(6):480-91. PubMed ID: 1652880
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
Kathol RG; Jaeckle RS; Lopez JF; Meller WH
Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
[TBL] [Abstract][Full Text] [Related]
19. Cortisol secretion in endogenous depression. I. Basal plasma levels.
Halbreich U; Asnis GM; Shindledecker R; Zumoff B; Nathan RS
Arch Gen Psychiatry; 1985 Sep; 42(9):904-8. PubMed ID: 4037990
[TBL] [Abstract][Full Text] [Related]
20. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
Schinke C; Hesse S; Stoppe M; Meyer K; Schmidt E; Orthgiess J; Bechmann L; Bresch A; Rullmann M; Luthardt J; Sabri O; Blüher M; Kratzsch J; Then Bergh F
Psychoneuroendocrinology; 2017 Apr; 78():39-47. PubMed ID: 28167369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
